Blog

Blog sidebar
13 Dec 2022

Poster #PTU-12, IASP Congress 2022

Oxaliplatin is a third-generation platinum-based chemotherapy drug widely used in the treatment of advanced metastatic colorectal cancer. Its use is limited by a cumulative and chronic neurotoxicity, characterized by dysesthesia and paresthesia in the distal extremities, spontaneous pain and loss of sensation. In nonhuman animals, oxaliplatin treatment produces significant behavioural nociceptive signs (cold allodynia), consistent [...]
17 Oct 2022

A model of Morphine-induced Tolerance in rats is now available

Opioid crisis: a social and economic issue From the observation... Pain is a major social issue requiring the continuous development of new analgesics. With a lack of effective and safe non opioid options for pain management, the use of drugs with opioid based mechanisms of action remains current and associated with numerous adverse effects, including [...]
22 Sep 2022

ALGOGram™ Fall session is coming . Register now! 🍂

ALGOGram™, your decision making guide! The registration for the upcoming ALGOGram™ session is now open! Assays seamlessly orchestrated during a 3 week experimental phase! 📅 From 10 November to 02 December Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas: Acute & tonic pain Inflammatory pain [...]
20 Sep 2022

A growing team!

Congratulations for their new position! We are pleased to welcome Adrien to our team and to congratulate Manon and Marie for their new position. Discover below their profile! Adrien Chartroule Trainee lab technician Manon Jallais Lab technician Marie Gaulmin Quality, Health & Safety Deputy Manager Adrien is currently ending his university degree. During his internship, [...]
09 Aug 2022

ALGOGram™ Back To School session is coming . Register now! 📚

Teaser of our Back To School ALGOGram session 📚 ALGOGram™, your decision making guide! The registration for the upcoming ALGOGram™ session is now open! Assays seamlessly orchestrated during a 3 week experimental phase! 📅 From 23 September to 14 October Explore the activity of your compounds in 10 fully validated pain models / tests across 5 [...]
30 Jun 2022

Mechanisms and Pharmacology of Bone Cancer Pain – 28JUNE2022

Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone. Bone cancer pain is very common, and patients with this type of pain may be difficult to treat.
Some models of bone cancer pain, which closely mirror the human condition, are providing insight into the mechanisms that drive bone cancer pain and guide the development of mechanism-based therapies to treat the cancer pain.

09 Jun 2022

REGISTER NOW FOR THE NEXT ANS BIOTECH WEBINAR, JUNE 28TH

Osteoarthritis (OA) of the knee is a complex peripheral joint disorder. This degenerative disease involving several joint tissues is characterized by damages to the articular cartilage. Pain is the primary symptom of OA and is the driving factor for patients to seek medical help. OA-associated pain is described as dull, aching pain that persists over time, but short episodes of more intense pain, known as flares, are also experience by many individuals.

15 May 2022

A growing team!

Welcome to ANS Biotech! We are pleased to welcome Léa, Elodie and Aristides to our team. Discover below their profile! Léa Decombas Trainee lab technician Elodie Jammes Animal care giver Aristides Zonon Trainee Bioinformatics Léa is currently ending her university degree. During her internship, she worked on the development of a new visceral pain model [...]